Therefore, regulating the expression of DDX17 in cardiomyocytes, maintaining mitochondrial homeostasis and normal autophagy function, and reducing cardiomyocyte apoptosis under pathological conditions are potential clinical diagnosis and treatment targets for myocardial injury and heart failure. The gene discussed is DDX17; the disease is heart failure.